iShares 7-10 Year Treasury Bond ETF vs Health Care Select Sector SPDR Fund — how do they compare? iShares 7-10 Year Treasury Bond ETF trades at $89.23 (market cap $41.13B), while Health Care Select Sector SPDR Fund trades at $169.87 (market cap $43.48B). The key difference: iShares 7-10 Year Treasury Bond ETF and Health Care Select Sector SPDR Fund are close in size by market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, iShares 7-10 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares 7-10 Year Treasury Bond ETF for 108 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| IEF | XLV | |
|---|---|---|
Market Cap | $41.13B | $43.48B |
Volume | 10,340,382 | 11,121,431 |
Sector | Fixed Income | — |
52-Week High | $97.99 | $175.68 |
52-Week Low | $88.92 | $141.95 |
Typical Hold Time | 108 Days | 100 Days |
Signals from Pluang's Aura AI — not financial advice
IEF trades at $89.295 with a modest 0.21% daily gain amid a challenging bond market environment. Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators remain neutral. Recent Treasury yield volatility and bond market selloffs have created headwinds for fixed income ETFs, while dividend distributions continue with recent payouts around $0.31-0.33 per share.
The outlook remains cautious as rising Treasury yields and inflation concerns pressure bond ETFs. While current yields provide income appeal, further rate increases could depress prices. Investors face the trade-off between defensive positioning and potential capital depreciation if the bond rout continues.
XLV trades at $168.81, up 1.03% today, with a bullish technical signal driven by moving averages. The ETF holds 61 healthcare stocks from the S&P 500, offering broad sector exposure at a low 0.08% expense ratio. Recent news highlights its defensive appeal amid market volatility and potential Fed rate hikes, with articles comparing it favorably to peers like IBB and PJP on cost and diversification.
Outlook is positive given healthcare's defensive growth profile and XLV's cost efficiency, but risks include political uncertainty from midterm elections and sector-specific volatility from drug trial outcomes. Wall Street sentiment is constructive, with the ETF near key resistance at $170.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity of greater than or equal to seven years and less than ten years. The fund will invest at least 80% of its assets in the component securities of the underlying index, and the fund will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index.
Read more on IEF →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →